Skip to Content

KU 270 (Oxybutynin Chloride Extended-Release 5 mg)

Pill with imprint KU 270 is White, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Kremers Urban.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 270

Oxybutynin chloride extended-release 5 mg KU 270
Oxybutynin chloride extended-release 5 mg KU 270 Front
Oxybutynin chloride extended-release 5 mg KU 270 Back
Oxybutynin chloride extended-release 5 mg KU 270
Oxybutynin chloride extended-release 5 mg KU 270

Oxybutynin Chloride Extended-Release

Imprint
KU 270
Strength
5 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Kremers Urban
Inactive Ingredients
lactose anhydrous, lactose monohydrate, mannitol, dextrose, anhydrous, tartaric acid, silicon dioxide, magnesium stearate, cellulose acetate, polyethylene glycol 400, titanium dioxide, ferrosoferric oxide, propylene glycol, hypromellose 2208 (100 mPa.s), triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
62175-0270 Kremers Urban Pharmaceuticals Inc.
68084-0480 Amerisource Health Services
42291-0633 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.